Cited by 55Lipid metabolism and disordersLipid metabolism and biosynthesisCholesterol and Lipid Metabolism

Nascent very-low-density lipoprotein triacylglycerol hydrolysis by lipoprotein lipase is inhibited by apolipoprotein E in a dose-dependent manner

Open access
JONG, C. Miek, DAHLMANS, E. H. Vivian, HOFKER, H. Marten, HAVEKES, M. Louis·1997·Biochemical Journal

Abstract

In the present study it was investigated whether apolipoprotein (apoE) can inhibit the lipoprotein lipase (LPL)-mediated hydrolysis of very-low-density-lipoprotein (VLDL) triacylglycerols (TAGs). Previous studies have suggested such an inhibitory role for apoE by using as a substrate for LPL either plasma VLDL or artificial TAG emulsions. To mimic the in vivo situation more fully, we decided to investigate the effect of apoE on the LPL-mediated TAG hydrolysis by using VLDL from apoE-deficient mice that had been enriched with increasing amounts of apoE. Furthermore, since plasma VLDL isolated from apoE-deficient mice was relatively poor in TAGs and strongly enriched in cholesterol as compared with VLDL from wild-type mice, we used nascent VLDL obtained by liver perfusions. Nascent VLDL (d < 1.006) isolated from the perfusate of the apoE-deficient mouse liver was rich in TAGs. Addition of increasing amounts of apoE to apoE-deficient nascent VLDL effectively decreased TAG lipolysis as compared with that of apoE-deficient nascent VLDL without the addition of apoE (63.1±6.3 and 20.8±1.8% of the control value at 2.7 μg and 29.6 μg of apoE/mg of TAG added respectively). Since, in vivo, LPL is attached to heparan sulphate proteoglycans (HSPG) at the endothelial matrix, we also performed lipolysis assays with LPL bound to HSPG in order to preserve the interaction of the lipoprotein particle with the HSPG-LPL complex. In this lipolysis system a concentration-dependent decrease in the TAG lipolysis was also observed with increasing amounts of apoE on nascent VLDL, although to a lesser extent than with LPL in solution (72.3±3.6% and 56.6±1.7% of control value at 2.7μg and 29.6 μg of apoE/mg TAGs added respectively). In conclusion, the enrichment of the VLDL particle with apoE decreases its suitability as a substrate for LPL in a dose-dependent manner.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1042/bj3280745

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The insufficiency of LPL appears to result from inhibition of this enzyme by apoE, which accumulates in VLDL/IDL/LDL-size lipoprotein particles.

    “As reported previously ( 36,37 ), the insuffi ciency of LPL appears to result from inhibition of this enzyme by apoE, which accumulates in VLDL/IDL/LDL-size lipoprotein particles.”

    From Molecular etiology of a dominant form of type III hyperlipoproteinemia caused by R142C substitution in apoE4 (2011) · cites this paper as [36]

    Table 4 and the Discussion show that adding apoE to nascent VLDL inhibits LPL-mediated triacylglycerol hydrolysis in vitro. The Discussion treats the physiological importance of this inhibition as unresolved; it does not establish that apoE accumulation in VLDL/IDL/LDL-size particles causes LPL insufficiency. Page numbers are not available in our copy. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 2

  1. Kowal, R. C., Herz, J., Goldstein, J. L., Esser, V. and Brown, M. S. (1989) Proc. Natl. Acad. Sci. U.S.A. 86, 5810-5814
  2. Williamson, R., Lee, D., Hagaman, J. and Maeda, N. (1992) Proc. Natl. Acad. Sci. USA. 89, 7134-7138

Cited by

Sorted by citations

Authors
JONG, C. M., DAHLMANS, E. H. V., HOFKER, H. M., & HAVEKES, M. L.
Affiliations
  • Netherlands Organisation for Applied Scientific Research (NL)
  • MGC-Department of Human Genetics, Leiden University, P.O. Box 9503, 2300 RA Leiden, The Netherlands
Venue
Biochemical Journal
Published
1997-12-15
Volume
328
Issue
3
Pages
745-750
ISSN
  • 0264-6021 (ISSN-L)
  • 1470-8728
OpenAlex
W1856179322
Cited by
55
References
0
Citations by year
2021: 1 · 2019: 2 · 2017: 1 · 2016: 2 · 2015: 1 · 2014: 4 · 2013: 1 · 2012: 1
FWCI
2.60
Type
journal article
Language
en
Open access
Locations
  • Biochemical Journal (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • TNO Repository (submittedVersion)
Funders
European Commission
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
  • Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
Keywords
apolipoprotein E, lipoprotein lipase, VLDL, lipolysis, lipolysis inhibition, ApoE-deficient mice, heparan sulfate proteoglycans, lipoprotein metabolism
MeSH terms
Animals, Apolipoproteins E, Cholesterol, Electrophoresis, Polyacrylamide Gel, Lipids, Lipolysis, Lipoprotein Lipase, Lipoproteins, VLDL, Liver, Mice, Inbred Strains, Triglycerides, Mice, Knockout, Heparan Sulfate Proteoglycans, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review